Literature DB >> 4189835

The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man.

R B Roberts.   

Abstract

The interaction in vitro between human granulocytes and meningococci in the presence of sera from volunteers immunized by Gotschlich et al. with purified group A and group C meningococcal polysaccharides was studied. Phagocytosis of meningococci did not occur in the presence of preimmunization sera. In all volunteers tested, group-specific opsonins were detected in groups A and C polysaccharide antisera. Opsonic activity appeared within 1 wk after immunization and persisted for at least 14 months. Titers of opsonic activity ranged from 1:20 to 1:320; highest titers were noted in 2-4 wk antisera. Meningococcal opsonins were detected in both 19S and 7S immunoglobulins. Opsonic activity in low-titer antisera depended on heat-labile factors present in both normal and immune sera, whereas phagocytosis was observed in the presence of heat-inactivated high-titer antisera. Phagocytosis of group A meningococci in the presence of certain group A polysaccharide antisera was inhibited by N-acetyl mannosamine, but not by mannose, mannosamine, N-acetyl glucosamine, N-acetyl galactosamine, or N-acetyl neuraminic acid. Absorption studies with sera from patients with natural meningococcal infections revealed that these polysaccharides are the major antiphagocytic determinants for group A and group C meningococci. These studies are consistent with previous reports suggesting that immunization with group A and group C polysaccharides may well provide group-specific protection against meningococcal infections.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 4189835      PMCID: PMC2138825          DOI: 10.1084/jem.131.3.499

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  [Action specificity of neuraminidase. The action of bacterial neuraminidase on isomeric N,O-diacetylneuraminic acid glycosides in the submaxilllary mucin of horse and cow].

Authors:  R Schauer; H Faillard
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1968-08

2.  Human monocytes: distinct receptor sites for the third component of complement and for immunoglobulin G.

Authors:  H Huber; M J Polley; W D Linscott; H H Fudenberg; H J Müller-Eberhard
Journal:  Science       Date:  1968-12-13       Impact factor: 47.728

3.  Complement dependent immune phagocytosis. I. Requirements for C'1, C'4, C'2, C'3.

Authors:  I Gigli; R A Nelson
Journal:  Exp Cell Res       Date:  1968-07       Impact factor: 3.905

4.  Sulfonamide-resistant meningococcal disease.

Authors:  R C Singer
Journal:  Med Clin North Am       Date:  1967-05       Impact factor: 5.456

5.  Antibiotic prophylaxis of carriers of sulfadiazine-resistant meningococci.

Authors:  J M Dowd; D Blink; C H Miller; P F Frank; W E Pierce
Journal:  J Infect Dis       Date:  1966-10       Impact factor: 5.226

6.  Comparison of the opsonic activity of gamma-G- and gamma-M-anti-Proteus globulins.

Authors:  J W Smith; J A Barnett; F P May; J P Sanford
Journal:  J Immunol       Date:  1967-02       Impact factor: 5.422

7.  The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.

Authors:  R B Johnston; M R Klemperer; C A Alper; F S Rosen
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

8.  Human immunity to the meningococcus. II. Development of natural immunity.

Authors:  I Goldschneider; E C Gotschlich; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

9.  The interaction in vitro between group B meningococci and rabbit polymorphonuclear leukocytes. Demonstration of type specific opsonins and bactericidins.

Authors:  R B Roberts
Journal:  J Exp Med       Date:  1967-11-01       Impact factor: 14.307

10.  Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides.

Authors:  E C Gotschlich; T Y Liu; M S Artenstein
Journal:  J Exp Med       Date:  1969-06-01       Impact factor: 14.307

View more
  39 in total

1.  Opsonophagocytosis of fluorescent polystyrene beads coupled to Neisseria meningitidis serogroup A, C, Y, or W135 polysaccharide correlates with serum bactericidal activity.

Authors:  Joseph Martinez; Tamara Pilishvili; Suzanne Barnard; Joseph Caba; Willie Spear; Sandra Romero-Steiner; George M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Immunologic defense in bacterial and viral meningitis in children.

Authors:  J Ströder; R Seger
Journal:  Eur J Pediatr       Date:  1976-12-09       Impact factor: 3.183

Review 3.  Role of oxidants in microbial pathophysiology.

Authors:  R A Miller; B E Britigan
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 4.  Cellular immune responses during gonococcal and meningococcal infections.

Authors:  M D Cooper; E J Moticka
Journal:  Clin Microbiol Rev       Date:  1989-04       Impact factor: 26.132

5.  Classification of Neisseria meningitidis group B into distinct serotypes. I. Serological typing by a microbactericidal method.

Authors:  C E Frasch; S S Chapman
Journal:  Infect Immun       Date:  1972-01       Impact factor: 3.441

Review 6.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

7.  Human opsonins to meningococci after vaccination.

Authors:  A Halstensen; B Haneberg; L O Frøholm; V Lehmann; C E Frasch; C O Solberg
Journal:  Infect Immun       Date:  1984-12       Impact factor: 3.441

8.  Comparison of radioimmunoassay and enzyme-linked immunosorbent assay in measurement of antibodies to Neisseria meningitidis group A capsular polysaccharide.

Authors:  E C Beuvery; M H Kayhty; A B Leussink; V Kanhai
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

9.  Immunochemical study of diverse surface antigens of a Staphylococcus aureus isolate from an osteomyelitis patient and their role in in vitro phagocytosis.

Authors:  W W Karakawa; D A Young
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

10.  Meningococcal infections. 5. Duration of polysaccharide-vaccine-induced antibody.

Authors:  M S Artenstein
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.